Oxidative stress in primary glomerular diseases: a comparative study

被引:0
|
作者
Suchita Markan
Harbir Singh Kohli
Kamal Sud
Monica Ahuja
Tarunveer S. Ahluwalia
Vinay Sakhuja
Madhu Khullar
机构
[1] Post Graduate Institute of Medical Education and Research (PGIMER),Department of Experimental Medicine and Biotechnology
[2] Post Graduate Institute of Medical Education and Research (PGIMER),Department of Nephrology
来源
关键词
Non-proliferative glomerulonephritis; Oxidative stress; Proliferative glomerulonephritis; Reactive oxygen species.;
D O I
暂无
中图分类号
学科分类号
摘要
Objective To evaluate the status of oxidative stress in patients with different primary glomerular diseases (PGD) which have differential predisposition to renal failure. Methods Seventy-three patients with PGD and 50 controls were enrolled in the study. They were sub-grouped into non-proliferative glomerulonephritis (NPGN) and proliferative glomerulonephritis (PGN). Levels of serum malondialdehyde (MDA), reactive nitrogen intermediates (RNI), plasma total homocysteine (tHcy), urine 8-isoprostane (8-IP), RBC thiols, glutathione-S-transferase (GST) and serum superoxide dismutase (SOD) were measured spectrophotometrically. Results PGD patients showed a significant increase in MDA, RNI, tHcy, 8-IP levels (P < 0.05) and decreased SOD, total thiols and protein bound thiol levels as compared to controls (P < 0.05). Significantly higher levels of tHcy, MDA and 8-IP (P < 0.05) and lower SOD enzyme activity (P < 0.05) were observed in PGN group as compared to NPGN and control groups. These changes remained significant even after adjustment was made for creatinine. Conclusions Oxidative stress in PGN is significantly higher than NPGN, indicating higher oxidative stress in these patients, independent of degree of renal dysfunction.
引用
收藏
页码:105 / 110
页数:5
相关论文
共 50 条
  • [41] Oxidative Stress in Neurodegenerative Diseases
    Ewa Niedzielska
    Irena Smaga
    Maciej Gawlik
    Andrzej Moniczewski
    Piotr Stankowicz
    Joanna Pera
    Małgorzata Filip
    Molecular Neurobiology, 2016, 53 : 4094 - 4125
  • [42] Neurodegenerative diseases and oxidative stress
    Barnham, KJ
    Masters, CL
    Bush, AI
    NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (03) : 205 - 214
  • [43] Oxidative Stress in Cardiovascular Diseases
    Dubois-Deruy, Emilie
    Peugnet, Victoriane
    Turkieh, Annie
    Pinet, Florence
    ANTIOXIDANTS, 2020, 9 (09) : 1 - 15
  • [44] Oxidative Stress and Hypertensive Diseases
    Loperena, Roxana
    Harrison, David G.
    MEDICAL CLINICS OF NORTH AMERICA, 2017, 101 (01) : 169 - +
  • [45] Neurodegenerative diseases and oxidative stress
    Emerit, J
    Edeas, A
    Bricaire, F
    BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (01) : 39 - 46
  • [46] OXIDATIVE STRESS AND CHRONIC DISEASES
    Utkualp, N.
    Ozdemir, A.
    OXIDATION COMMUNICATIONS, 2015, 38 (04): : 1690 - 1696
  • [47] Oxidative Stress in Retinal Diseases
    Nishimura, Yuhei
    Hara, Hideaki
    Kondo, Mineo
    Hong, Samin
    Matsugi, Takeshi
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2017, 2017
  • [48] Oxidative stress in neurodegenerative diseases
    Simonian, NA
    Coyle, JT
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1996, 36 : 83 - 106
  • [49] Oxidative Stress in Neurodegenerative Diseases
    Niedzielska, Ewa
    Smaga, Irena
    Gawlik, Maciej
    Moniczewski, Andrzej
    Stankowicz, Piotr
    Pera, Joanna
    Filip, Magorzata
    MOLECULAR NEUROBIOLOGY, 2016, 53 (06) : 4094 - 4125
  • [50] Oxidative stress and neurodegenerative diseases: a bidirectional Mendelian randomization study
    Yin, Zihan
    Yang, Zuoqin
    Liu, Yiwei
    Zhao, Ling
    Liang, Fanrong
    NUTRITIONAL NEUROSCIENCE, 2025, 28 (01) : 107 - 115